Data from European Association for the Study of Obesity (EASO) and the European Society of Hypertension (ESH) - Curated by Toby Galbraith - Last updated 30 November 2016

Status

live

Latest update

07-Mar-12

The present joint scientific statement provides an overview on the interaction between obesity and arterial hypertension from a pathophysiological, epidemiological, and clinical point of view. An important goal of this joint effort is to identify areas of uncertainty that ought to be studied in more detail. In particular, a focus is made on difficulties in treating hypertension in these patients.

Read full guideline

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Hyperammonaemia

Hyperammonaemia can result in serious neurological damage or death. Could you recognise the signs and symptoms?

Visit Hyperammonaemia

Lysosomal Acid Lipase Deficiency (LAL-D)

Could you correctly diagnose and treat lysosomal acid lipase deficiency?

Visit Lysosomal Acid Lipase Deficiency (LAL-D)

Related Content